Holds 2 active US DMFs and one valid CEP for dapsone, filing since 2020. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF and one valid CEP for dapsone, filing since 2023. Its 2024 FDA inspection closed as VAI.
Holds 2 active US DMFs for dapsone, filing since 2019. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 29 markets.
Holds one valid CEP for dapsone, filing since 2025. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for dapsone, filing since 2013. Its 2024 FDA inspection closed as VAI.
Holds one active US DMF for dapsone, filing since 2004.
Registered with DAV (Vietnam) for dapsone. Its GMP is recognised in 1 market.
This page filters the worldwide Dapsone manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free